AIM at Melanoma

AIM at Melanoma is globally engaged and locally invested in advancing the battle against melanoma through groundbreaking research, legislative reform, education, and patient and caregiver support.

Latest from AIM at Melanoma

Aiming for New Targets: Emerging Therapies in Melanoma

July 17, 2021

Article

In its Speaking Out video series, on behalf of Aim at Melanoma, CURE ® spoke with Dr. Sunandana Chandra about emerging therapies in melanoma.

Understanding Treatment Options in Melanoma

July 09, 2021

Video

On behalf of AiM at Melanoma, Drs. Jeffrey Farma and Sunandana Chandra discuss current and future treatment options for melanoma, including a rare subtype.

What’s Next After Hedgehog Therapy Fails for Basal Cell Carcinoma?

March 01, 2021

Article

A patient with recurrent basal cell carcinoma discusses his cancer journey, his latest challenge and how he’s now prioritized quality of life over quantity.

In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses

February 23, 2021

Article

Intratumoral injection—the boosting of the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses—is a promising treatment method because it’s effective AND it seems to cause fewer toxicities for the patient than combination systemic immunotherapy.

Friendship is Forever

February 16, 2021

Article

Gina Roller’s best friend, Kerri-Lynn Larimer, adopted and lived by the motto “crazy not to” long before she was diagnosed with metastatic melanoma.

Why Is the Tissue Bank So Important For Melanoma Research?

February 09, 2021

Article

We answer this question with the help of Mohammed Kashani-Sabet, M.D., the Director, Center for Melanoma Research and Treatment; and Medical Director, Cancer Center, California Pacific Medical Center.